Xtampza ER — CareFirst (Caremark)
Pain associated with a terminal condition
Approval duration
12 months for pain associated with cancer, sickle cell disease, terminal condition, or hospice/palliative care; 6 months for chronic pain
Pain associated with a terminal condition
12 months for pain associated with cancer, sickle cell disease, terminal condition, or hospice/palliative care; 6 months for chronic pain